Solriamfetol for attention deficit hyperactivity disorder

CNS Spectr. 2022 Dec;27(6):662-663. doi: 10.1017/S1092852921000328. Epub 2021 Apr 19.

Authors

Ahmed Naguy¹, Adel El-Sheshaie², Dalal H Elsori³, Bibi Alamiri^{1

4}

Affiliations

¹ Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Shuwaikh, State of Kuwait.
² Neuropsychiatry Department, Alexandria Faculty of Medicine, Egypt.
³ Developmental and Behavioural Paediatrician, Rhode Island Hospital, Brown University, Providence, Rhode Island, United States.
⁴ Tufts University, Medford, Massachusetts, USA.

PMID: 33870884
DOI: 10.1017/S1092852921000328

No abstract available

Keywords: ADHD; Solriamfetol; adolescents.

Publication types

Letter

MeSH terms

Attention Deficit Disorder with Hyperactivity* / drug therapy
Carbamates
Humans
Phenylalanine

Substances

solriamfetol
Carbamates
Phenylalanine